Why location matters: associations between county-level characteristics and availability of National Cancer Oncology Research Program and National Cancer Institute sites.

IF 3.4 Q2 ONCOLOGY JNCI Cancer Spectrum Pub Date : 2024-04-30 DOI:10.1093/jncics/pkae038
Nicole E Caston, Courtney P Williams, Emily B Levitan, Russell Griffin, Andres Azuero, Stephanie B Wheeler, Gabrielle B Rocque
{"title":"Why location matters: associations between county-level characteristics and availability of National Cancer Oncology Research Program and National Cancer Institute sites.","authors":"Nicole E Caston, Courtney P Williams, Emily B Levitan, Russell Griffin, Andres Azuero, Stephanie B Wheeler, Gabrielle B Rocque","doi":"10.1093/jncics/pkae038","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The majority of patients with cancer seek care at community oncology sites; however, most clinical trials are available at National Cancer Institute (NCI)-designated sites. Although the NCI National Cancer Oncology Research Program (NCORP) was designed to address this problem, little is known about the county-level characteristics of NCORP site locations.</p><p><strong>Methods: </strong>This cross-sectional analysis determined the association between availability of NCORP or NCI sites and county-level characteristic theme percentile scores from the Center for Disease Control and Prevention's Social Vulnerability Index themes. Health Resources and Services Administration's Area Health Resource Files were used to determine contiguous counties. We estimated risk ratios and 95% confidence intervals (CIs) using modified Poisson regression models to evaluate the association between county-level characteristics and site availability within singular and singular and contiguous counties.</p><p><strong>Results: </strong>Of 3141 included counties, 14% had an NCORP, 2% had an NCI, and 1% had both sites. Among singular counties, for a standard deviation increase in the racial and ethnic theme score, there was a 22% higher likelihood of NCORP site availability (95% CI = 1.10 to 1.36); for a standard deviation increase in the socioeconomic status theme score, there was a 24% lower likelihood of NCORP site availability (95% CI = 0.67 to 0.87). Associations were of smaller magnitude when including contiguous counties. NCI sites were located in more vulnerable counties.</p><p><strong>Conclusions: </strong>NCORP sites were more often in racially diverse counties and less often in socioeconomically vulnerable counties. Research is needed to understand how clinical trial representation will increase if NCORP sites strategically increase their locations in more vulnerable counties.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163183/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkae038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The majority of patients with cancer seek care at community oncology sites; however, most clinical trials are available at National Cancer Institute (NCI)-designated sites. Although the NCI National Cancer Oncology Research Program (NCORP) was designed to address this problem, little is known about the county-level characteristics of NCORP site locations.

Methods: This cross-sectional analysis determined the association between availability of NCORP or NCI sites and county-level characteristic theme percentile scores from the Center for Disease Control and Prevention's Social Vulnerability Index themes. Health Resources and Services Administration's Area Health Resource Files were used to determine contiguous counties. We estimated risk ratios and 95% confidence intervals (CIs) using modified Poisson regression models to evaluate the association between county-level characteristics and site availability within singular and singular and contiguous counties.

Results: Of 3141 included counties, 14% had an NCORP, 2% had an NCI, and 1% had both sites. Among singular counties, for a standard deviation increase in the racial and ethnic theme score, there was a 22% higher likelihood of NCORP site availability (95% CI = 1.10 to 1.36); for a standard deviation increase in the socioeconomic status theme score, there was a 24% lower likelihood of NCORP site availability (95% CI = 0.67 to 0.87). Associations were of smaller magnitude when including contiguous counties. NCI sites were located in more vulnerable counties.

Conclusions: NCORP sites were more often in racially diverse counties and less often in socioeconomically vulnerable counties. Research is needed to understand how clinical trial representation will increase if NCORP sites strategically increase their locations in more vulnerable counties.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为什么地点很重要?县级特征与 NCORP 和 NCI 站点可用性之间的关联。
背景:大多数癌症患者都在社区肿瘤医院接受治疗;然而,大多数临床试验都是在国家癌症研究所(NCI)指定的医院进行的。虽然美国国家癌症研究所(NCI)的国家癌症肿瘤研究计划(NCORP)旨在解决这一问题,但人们对国家癌症肿瘤研究计划地点的县级特征知之甚少:这项横断面分析确定了 NCORP 或 NCI 站点的可用性与县级特征主题百分位数(来自疾病预防控制中心的社会脆弱性指数主题)之间的关联。我们使用卫生资源与服务管理局的地区卫生资源档案来确定毗连县。我们使用修正的泊松回归模型估算了风险比和 95% 的置信区间 (CI),以评估单一县和单一及毗邻县的县级特征与场所可用性之间的关联:在纳入的 3141 个县中,14% 的县拥有 NCORP,2% 的县拥有 NCI,1% 的县同时拥有这两个站点。在单一县中,种族和民族主题得分每增加一个标准差 (SD),NCORP 站点可用性的可能性就会增加 22%(95% CI 1.10-1.36);社会经济地位主题得分每增加一个标准差,NCORP 站点可用性的可能性就会降低 24%(95% CI 0.67-0.87)。如果将毗连县也包括在内,则相关性较小。NCI站点位于更脆弱的县:NCORP研究机构更多位于种族多样化的县,而较少位于社会经济脆弱的县。需要开展研究,以了解如果 NCORP 机构战略性地增加其在弱势县的位置,临床试验的代表性将如何增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
期刊最新文献
Association between GLP-1RA use and progression of MGUS to Multiple Myeloma among diabetic patients. Sexual Function and Satisfaction in Young Women with Breast Cancer: A Five-Year Prospective Study. County-level racial disparities in prostate cancer specific mortality from 2005 to 2020. Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis. Neighborhood vulnerability and associations with poor health-related quality of life among adult survivors of childhood cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1